SYGNIS successfully completes patient recruitment for AXIS 2 Study
328 patients recruited at about 80 stroke centres in eight European countries
10-Aug-2011 -
SYGNIS Pharma AG announced the successful completion of the patient recruitment for its AXIS 2 Study. This randomized, double-blind study is designed to demonstrate the efficacy of AX200 (G-CSF) for the treatment of patients with acute ischemic stroke. Dr. Frank Rathgeb, Chief Medical Officer of ...
clinical trials
stroke